News

Certificate Available for Download

EN ISO 13485:2016, issued May 09^th, 2023

DaraEx plus

A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉. DaraEx plus is available from inno-train ⧉.

imuPep Class I Peptide Binding Analysis

Our innovative, high-throughput service for you to confirm your target peptides, e.g. in vaccine and cancer research.

Instructions for Use Available for Download

Instructions for Use and Material Safety Data Sheets for imusyn's products DaraEx plus, DaraEx, and rBGA are now available for download.

Certificate Available for Download

Certificate Directive 98/79/EC, issued May 20^th, 2022

HLA Shop

Now available: recombinant HLA class I and HLA class II proteins from imusyn.

New KN Blood Group Antigens

A recent publication in Transfusion features our new KN antigens ⧉, available from inno-train ⧉.

Funding

We are proud to announce that the European Regional Development Fund (EFRE) funds the realization of the imuStain project at imusyn.

Welcome to imusyn.

Our mission is to develop and produce outstanding diagnostic tests in the field of transfusion medicine and organ transplantation. We also support the development of in-vitro diagnostics and provide customized recombinant protein production.